Retrotope retrotope.com


Public list: Pharma Startups (4732) Rare Diseases (230)

Retrotope has created a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases. The unique mechanism of Retrotope's platform prevents cellular damage and recovers cellular function damaged by lipid peroxidation due to oxidative stress. Retrotope's first product candidate, RT001, is being clinically tested in Friedreich's ataxia (FA), an untreated fatal orphan disease. Other stabilized lipid drugs based on Retrotope's transformational platform technolo...Show all

Retrotope has created a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases. The unique mechanism of Retrotope's platform prevents cellular damage and recovers cellular function damaged by lipid peroxid...Show all

Company (Alive / Active)

Phone: 650-917-9256

Fax:

4300 El Camino Real
Suite 201
Los Altos, 94022
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Retrotope $17.4M Jan 3, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Retrotope Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Life Science AngelsAngel Investor (Group)Palo Alto, California, United StatesSeries B, Series A - II, Series A, Angel
Undisclosed InvestorsOtherDebt - II, Debt
See all 2 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Isotopically modified compounds and their use as food supplements Mar 23, 2016 Apr 11, 2017 Patent
Isotopically modified compounds and their use as food supplements Nov 24, 2014 Apr 26, 2016 Patent
Isotopically modified compounds and their use as food supplements Mar 08, 2007 Dec 09, 2014 Patent
Therapeutic substances that modulate genome methylation Jan 27, 2014 Dec 02, 2014 Patent
Therapeutic substances that modulate genome methylation Mar 13, 2009 Jan 28, 2014 Patent
See all 6 patents